MHRA Criticizes EU Drug Verification Plan as Costly

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) is taking issue with an EU plan to scan all drugs at the point of dispensing, saying the cost of providing scanners at all healthcare outlets is too burdensome. The point-of-sale scans are part of a proposed drug authentication system outlined by the European Commission in a 2011 concept paper. The system would require prescription medicines to bear safety features — including a serial number — that would reveal when a product had been tampered with, regardless of how it’s supplied.
International Pharmaceutical Regulatory Monitor